Publication: Chromosome and abnormalities are associated with an even worse outcome and karyotype complexity in patiens with chronic lymphocytic leukemia and TP53 A
dc.contributor.author | Blanco, A | |
dc.contributor.author | Puiggros, A | |
dc.contributor.author | Baliakas, P | |
dc.contributor.author | Athanasiadou, A | |
dc.contributor.author | García-Malo, MD | |
dc.contributor.author | Collado, R | |
dc.contributor.author | Xochelli, A | |
dc.contributor.author | Rodríguez-Rivera, M | |
dc.contributor.author | Ortega, M | |
dc.contributor.author | Calasanz, MJ | |
dc.contributor.author | Luño, E | |
dc.contributor.author | Vargas, MT | |
dc.contributor.author | Grau, J | |
dc.contributor.author | Martínez-Laperche, C | |
dc.contributor.author | Valiente, A | |
dc.contributor.author | Papaioannou, G | |
dc.contributor.author | Cervera, J | |
dc.contributor.author | Anagnostopoulos, A | |
dc.contributor.author | Piñán, MA | |
dc.contributor.author | Stalika, E | |
dc.contributor.author | Hernández-Rivas, JM | |
dc.contributor.author | Batlle, A | |
dc.contributor.author | Salido, M | |
dc.contributor.author | Ortuño, F | |
dc.contributor.author | Melero, c | |
dc.contributor.author | Robles, D | |
dc.contributor.author | Ferrer, A | |
dc.contributor.author | Ivars, D | |
dc.contributor.author | Rodríguez, A | |
dc.contributor.author | González, M | |
dc.contributor.author | Bosch, F | |
dc.contributor.author | Abrisqueta, P | |
dc.contributor.author | Stamatopoulos, K | |
dc.contributor.author | Espinet, B | |
dc.contributor.authoraffiliation | [Blanco,A; Puiggros,A; Rodríguez-Rivera,M; Salido,M; Melero,C; Ferrer,A; Espinet,B] Laboratori de Citogenètica Molecular, Laboratori de Citologia Hematològica, Servei de Patologia, Hospital del Mar/Grup de Recerca Translacional en Neoplàsies Hematològiques, Institut Hospital del Mar d’Investigacions Mèdiques(IMIM), Barcelona, Spain. [Baliakas,P] Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. [Athanasiadou,A; Papaioannou,G; Anagnostopoulos,A] Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece. [García-Malo,MD; Ortuño,F] Servicio de Hematología, Hospital Universitario Morales Meseguer, Murcia, Spain. [Collado,R; Ivars,D] Servicio de Hematología, Consorcio Hospital General Universitario, Valencia, Spain. [Xochelli,A; Stalika,E] Institute of Applied Biosciences, CERTH, Thessaloniki, Greece. [Ortega,M; Bosch,F; Abrisqueta,P] Laboratorio de Citogenética y Servicio de Hematología, Hospital Vall d’Hebron, Barcelona, Spain. [Calasanz,MJ] Servicio de Citogenética, Departamento de Genética, Universidad de Navarra, Pamplona, Spain. [Luño,E] Servicio de Hematología, Hospital Universitario Central de Asturias, Oviedo, Spain. [Vargas,MT; Rodríguez,A] Hospital Universitario Virgen de la Macarena, Sevilla, Spain. [Grau,J] Servei Laboratori Hematologia, ICO-Hospital Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), Universitat Autònoma de Barcelona, Badalona, Spain. [Martínez-Laperche,C] Laboratorio de Genética Hematológica, Servicio de Hematología. Hosp. G.U. Gregorio Marañón, Madrid. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. [Valiente,A] Servicios de Genética y Hematología, Complejo Hospitalario de Navarra, Pamplona, Spain. [Cervera,J] Unidad de Genética, Hospital Universitario La Fe, Valencia, Spain. [Piñán,MA] Servicio de Hematología, Hospital de Cruces, Bilbao, Spain. [Hernández-Rivas,MJ] Servicio de Hematología, Hospital Universitario de Salamanca, IBSAL, IBMCC, Centro de Investigación del Cáncer, Universidad de Salamanca, CSIC, Salamanca, Spain. [Batlle,A] Servicio de Hematología, Hospital Universitario Marqués de Valdecilla, Santander, Spain. [Robles,D] Servicio de Hematología, Hospital Txagorritxu, Vitoria, Spain. [Stamatopoulos,K] Hematology Department and HCT Unit, G. Papanicolaou Hospital/Institute of Applied Biosciences, CERTH, Thessaloniki, Greece. | es |
dc.date.accessioned | 2016-11-23T12:11:34Z | |
dc.date.available | 2016-11-23T12:11:34Z | |
dc.date.issued | 2016-06-09 | |
dc.description.abstract | TP53 aberrations (deletions and/or mutations, TP53ab) in chronic lymphocytic leukemia (CLL) are associated with dismal clinical outcome and reduced life expectancy. However, mounting evidence suggests that within cases carrying TP53ab other cytogenetic features may also influence the clinical outcome. Alterations in chromosome 8, in particular 8p losses (affecting several regions, from 8p12 to 8p23) and 8q gains (usually involving 8q24, where MYC is located), are enriched in TP53ab patients and have been proposed as features with potential prognostic value within this aggressive group. | es |
dc.description.version | Yes | es |
dc.identifier.citation | Blanco G, Puiggros A, Baliakas P, Athanasiadou A, García-Malo MD, Collado R, el al. Chromosome and abnormalities are associated with an even worse outcome and karyotype complexity in patiens with chronic lymphocytic leukemia and TP53 A. HAEMATOLOGICA. 2016, Vol. 101, (S1) pp. 229-230 | es |
dc.identifier.essn | 1592-8721 | |
dc.identifier.issn | 0390-6078 | |
dc.identifier.uri | http://hdl.handle.net/10668/2539 | |
dc.journal.title | Haematologica | |
dc.language.iso | en | |
dc.publisher | Ferrata Storti Foundation | es |
dc.relation.publisherversion | http://www.haematologica.org/content/101/s1 | es |
dc.rights.accessRights | open access | |
dc.subject | Cromosomas humanos par 8 | es |
dc.subject | Citogenética | es |
dc.subject | Leucemia linfoide | es |
dc.subject | Esperanza de vida | es |
dc.subject | Eliminación de secuencia | es |
dc.subject.mesh | Medical Subject Headings::Anatomy::Cells::Cellular Structures::Chromosomes::Chromosomes, Mammalian::Chromosomes, Human::Chromosomes, Human, 6-12 and X::Chromosomes, Human, Pair 8 | es |
dc.subject.mesh | Medical Subject Headings::Disciplines and Occupations::Natural Science Disciplines::Biological Science Disciplines::Biology::Genetics::Cytogenetics | es |
dc.subject.mesh | Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans | es |
dc.subject.mesh | Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia, Lymphoid | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Life Expectancy | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variation::Mutation | es |
dc.subject.mesh | Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Prevalence | es |
dc.subject.mesh | Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Mutagenesis::Sequence Deletion | es |
dc.title | Chromosome and abnormalities are associated with an even worse outcome and karyotype complexity in patiens with chronic lymphocytic leukemia and TP53 A | es |
dc.type | conference presentation | |
dc.type.hasVersion | VoR | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Blanco_ChromosomeAbnormalitiesAssociated .pdf
- Size:
- 174.15 KB
- Format:
- Adobe Portable Document Format
- Description:
- Meeting Abstract